Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 16/20 | 0.37 |
| ▸ | HTR2A | P28223 | 15/20 | 0.37 |
| ▸ | DRD2 | P14416 | 14/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CRHBP | P24387 | 1/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6754171 | 0.92 | HTT (0.38) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5635052 | 0.91 | ALDH1A1 (0.38) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL6756093 | 0.91 | EPHX2 (0.38) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5638939 | 0.91 | HTR2C (0.41) | HTR2CHTR2ADRD2HTR2B | |
| SCHEMBL5636167 | 0.89 | EPHX2 (0.37) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL6756119 | 0.89 | HTR2C (0.42) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5635088 | 0.88 | EPHX2 (0.37) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5636090 | 0.88 | HTR2C (0.37) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5637410 | 0.87 | EPHX2 (0.36) | HTR2CHTR2ADRD2KDM4EALDH1A1 | |
| SCHEMBL5635106 | 0.87 | HTR2C (0.36) | HTR2CHTR2ADRD2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |